Advancement of potential gene therapy could offer new hope for children with Batten disease

A new study shows that delivery of gene therapy to correct the gene mutations that cause CLN2 disease, or Batten disease, directly into the cerebrospinal fluid (CSF) has potential therapeutic effects.

Silo Pharma Initiates Feasibility Study of SPC-15 Novel Intranasal Formulation for PTSD – Psychedelic Alpha

Investigational New Drug (IND) submission to FDA on target for Q1 2024 SPC-15, is a novel Serotonin 4 receptor agonist against stress, developed in conjunction

September 12, 2023

Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast | Psychedelic Invest

Mushrooms Inc. (OTC: MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting

July 20, 2023

Verano, Green Thumb & MariMed’s Strong Q2: Unpacking The Cannabis Earnings Surge

Verano, Green Thumb & MariMed’s Strong Q2: Unpacking The Cannabis Earnings Surge In a recent series of equity research reports, Pablo Zuanic of Zuanic &

February 14, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.